Back to today’s briefing

Story perspectives

Moderna Leads S&P 500 Rebound After Melanoma Vaccine News

9/1/2026

35 8 Full Breakdown

Summary

Story summary

Jim Cramer said August marked a comeback month for stocks battered by bearish narratives.
Moderna led the S&P 500 in August after announcing promising results for its experimental melanoma vaccine with Merck.
Palantir, Veeva Systems, Salesforce and ServiceNow rebounded as investors dismissed AI-related durability concerns.
Super Micro Computer surged on booming AI data-center memory demand despite ongoing scrutiny of its China business.

1 of 1

Story summary

Jim Cramer said August marked a comeback month for stocks battered by bearish narratives.
Moderna led the S&P 500 in August after announcing promising results for its experimental melanoma vaccine with Merck.
Palantir, Veeva Systems, Salesforce and ServiceNow rebounded as investors dismissed AI-related durability concerns.
Super Micro Computer surged on booming AI data-center memory demand despite ongoing scrutiny of its China business.